Similar articles

• [New investigations on antiactinic properties of antipyrine].

  QUIROGA MI, MAGNIN PH. QUIROGA MI, et al. Actas Dermosifiliogr. 1953 Mar;44(6):399-404. Actas Dermosifiliogr. 1953. PMID: 13065164 Undetermined Language. No abstract available.
• Electrochemical, quantum-chemical and antioxidant properties of antipyrine and its derivatives.

  Bashkatova NV, Korotkova EI, Karbainov YA, Yagovkin AY, Bakibaev AA. Bashkatova NV, et al. J Pharm Biomed Anal. 2005 Apr 29;37(5):1143-7. doi: 10.1016/j.jpba.2004.11.046. Epub 2005 Jan 7. J Pharm Biomed Anal. 2005. PMID: 15862698
• Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.

  Fujioka H, Tan T. Fujioka H, et al. J Pharmacobiodyn. 1982 Jul;5(7):475-84. doi: 10.1248/bpb1978.5.475. J Pharmacobiodyn. 1982. PMID: 6982326
• Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.

  Denlinger CL, Stryker KK, Slusher LB, Vesell ES. Denlinger CL, et al. Clin Pharmacol Ther. 1987 May;41(5):522-30. doi: 10.1038/clpt.1987.67. Clin Pharmacol Ther. 1987. PMID: 3568537
• [The use of the antipyrine test for studying microsomal drug oxidation].

  Viktorov AP, Rybak AT. Viktorov AP, et al. Farmakol Toksikol. 1990 Jan-Feb;53(1):74-7. Farmakol Toksikol. 1990. PMID: 2184052 Review. Russian.